Tekmira Receives $14.5 Million Milestone Payment

Tekmira Pharmaceuticals TKMR confirmed today that it has received US$14.5 million of the net US$16.5 million in near term payments as outlined in the terms of an option agreement signed with Monsanto, which supports the application of Tekmira's proprietary delivery technology and related intellectual property (IP) for use in agriculture. " See full press release